Key facts
- This page summarizes Kurt A. Gustafson's Form 4 filing for OmniAb, Inc. (OABI).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 19 Feb 2025, 20:51.
Kurt A. Gustafson - 16 Feb 2025 Form 4 Insider Report for OmniAb, Inc. (OABI)
- Reporting relationship
- Executive VP, Finance and CFO
- Issuer ticker
- OABI
- Reported as of
- 16 Feb 2025
- Net transaction value
- -$26,626
- SEC form
- 4
- Accepted by SEC
- 19 Feb 2025, 20:51:40 UTC
- Prior SEC filing
- 22 Jan 2025
- Next SEC filing
- 01 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Charles S. Berkman, Attorney-in-Fact For: Kurt A. Gustafson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kurt A. Gustafson filed Form 4 for OmniAb, Inc. (OABI) on 19 Feb 2025.
Change
- Previous filing in this sequence was filed on 22 Jan 2025.
- Current net transaction value: -$26,626.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OABI
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +13,541
- Change %
- +6.8%
- Price
- $0.000000
- Shares after
- 213,466
- Date
- 16 Feb 2025
- Ownership
- Direct
- Footnotes
- F1, F2, F3
OABI
transaction
Common Stock
Sale
- Transaction value
- $26,626
- Shares
- -7,255
- Change %
- -3.4%
- Price
- $3.67
- Shares after
- 206,211
- Date
- 19 Feb 2025
- Ownership
- Direct
- Footnotes
- F4, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OABI
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -13,541
- Change %
- -9.9%
- Price
- $0.000000
- Shares after
- 123,912
- Date
- 16 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,541
- Exercise price
- $0.000000
- Footnotes
- F1, F2
OABI
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +56,250
- Change %
- +45%
- Price
- $0.000000
- Shares after
- 180,162
- Date
- 18 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 56,250
- Exercise price
- $0.000000
- Footnotes
- F2, F6
OABI
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +337,500
- Change %
- Price
- $0.000000
- Shares after
- 337,500
- Date
- 18 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 337,500
- Exercise price
- $3.66
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 16, 2025.
Footnote F2
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F3
The total includes the transfer of 12,795 OABI common stock shares on February 4, 2025 to the reporting person's ex-spouse per a domestic relations order.
Footnote F4
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent discretionary trades by the reporting person.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.71. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F6
The RSU grant vests in three substantially equal annual installments beginning on February 18, 2026.
Footnote F7
The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.